Alto Neuroscience ANRO EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's EPS (basic)?
- Alto Neuroscience (ANRO) reported EPS (basic) of -$0.80 in Q1 2026.
- How has Alto Neuroscience's EPS (basic) changed year-over-year?
- Alto Neuroscience's EPS (basic) decreased by 42.9% year-over-year, from -$0.56 to -$0.80.
- What is the long-term trend for Alto Neuroscience's EPS (basic)?
- Over 2 years (2023 to 2025), Alto Neuroscience's EPS (basic) has grown at a -52.6% compound annual growth rate (CAGR), from -$9.72 to -$2.18.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.